Ignite Creation Date:
2024-05-06 @ 6:07 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05549258
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2022-07-22
Brief Title:
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-13
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-22
First Submit QC Date:
September 19 2022
Study First Post Date:
2022-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL